… The use of inhaled corticosteroid (ICS) in patients with chronic obstructive … of pneumonia
in Japanese patients with COPD. We retrospectively investigated the occurrence of pneumonia …

… Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung diseases has
been associated with a higher risk of pneumonia, particularly in COPD. The risk of pneumonia …

… risk in patients with asthma remains unclear. This review discusses the effect of ICS on
pneumonia … Asthma is associated with an increased risk of pneumonia. Several hypotheses have …

… the impact of prior use of inhaled corticosteroids (ICS) in patients … Inhaled corticosteroid
use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia…

… We have examined systematic reviews assessing the risk of pneumonia associated with …
%–78% increased risk of pneumonia, while only slightly increased risk or no risk was found for …

… inhaled corticosteroids (ICSs) as the first line of control therapy. ICSs are associated with an
increased risk of pneumonia in … studies reported an increased risk of pneumonia; however, …

… of pneumonia development in patients with chronic obstructive pulmonary disease (COPD)
receiving inhaled corticosteroid (… and the incidence of pneumonia between COPD patients …

… compare the effect of inhaled corticosteroid (ICS) and ICS/long-acting β-agonist (LABA) in a
single inhaler on all-cause mortality and adverse events, such as pneumonia and fracture, in …

… chronic obstructive pulmonary disease (COPD) who take inhaled corticosteroids (ICS) have
a higher risk of pneumonia than those who don’t. However, it is not clear how big this risk is. …

… had a recorded episode of pneumonia before the index date. Our … risk of pneumonia with
the two treatments—that is, any excess risk was linked with the choice of inhaled corticosteroid/…